Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JANET RENE KEAIS-GROSS

Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation

NPI
1649235490
CMS profile
695197
Location
TYLER, TX

General Payments · PY2018–2019

$424.44

  • Reported across 22 records
  • CMS publication 2026-01-23

Latest program year · PY2019

$229.30

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2019 · sorted by reported total

By paying entity

PY2019 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $83.61 5
Biogen, Inc. $41.40 2
Neurocrine BioSciences, Inc. $40.70 2
Acorda Therapeutics, Inc $29.13 1
UCB, Inc. $22.56 1
Lilly USA, LLC $11.90 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $195.14 10
PY2019 $229.30 12

Payment records · PY2019 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2019 2018 Record-level detail is published for PY2019; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Acorda Therapeutics, Inc $29.13 04/01/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 633496973 CMS
Amgen Inc. $19.34 05/02/2019 Food and Beverage Undisputed 01/23/2026 662461699 CMS
Amgen Inc. $14.87 05/28/2019 Food and Beverage Undisputed 01/23/2026 662461705 CMS
Amgen Inc. $15.08 08/12/2019 Food and Beverage Undisputed 01/23/2026 662461711 CMS
Amgen Inc. $13.80 09/09/2019 Food and Beverage Undisputed 01/23/2026 662461713 CMS
Amgen Inc. $20.52 10/31/2019 Food and Beverage Undisputed 01/23/2026 662461715 CMS
Biogen, Inc. $22.50 08/05/2019 Food and Beverage Undisputed 01/23/2026 660626525 CMS
Biogen, Inc. $18.90 10/03/2019 Food and Beverage Undisputed 01/23/2026 660626527 CMS
Lilly USA, LLC $11.90 08/29/2019 Food and Beverage Undisputed 01/23/2026 657876577 CMS
Neurocrine Biosciences, Inc. $21.13 06/20/2019 Food and Beverage Undisputed 01/23/2026 693140257 CMS
Neurocrine Biosciences, Inc. $19.57 08/15/2019 Food and Beverage Undisputed 01/23/2026 693140259 CMS
UCB, Inc. $22.56 04/29/2019 Food and Beverage Undisputed 01/23/2026 688278509 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019
Source files
Dataset page · Bulk file · PY2018 , PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.